CME Group Stock Price, News & Analysis (NASDAQ:CME)

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group announced a quarterly dividend on Wednesday, August 7th. Stockholders of record on Tuesday, September 10th will be paid a dividend of $0.75 per share on Wednesday, September 25th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, September 9th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings data on Wednesday, July, 31st. The financial services provider reported $1.76 EPS for the quarter, beating the consensus estimate of $1.75 by $0.01. The financial services provider earned $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The company's quarterly revenue was up 20.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.74 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for CME Group.

CME Group will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

14 equities research analysts have issued 12 month target prices for CME Group's stock. Their predictions range from $150.00 to $240.00. On average, they anticipate CME Group's share price to reach $203.2308 in the next twelve months. This suggests that the stock has a possible downside of 3.8%. View Analyst Price Targets for CME Group.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 2 sell ratings, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CME Group.

Media coverage about CME stock has trended somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CME Group earned a news sentiment score of -1.3 on InfoTrie's scale. They also assigned news articles about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for CME Group.

Some companies that are related to CME Group include Intercontinental Exchange (ICE), DEUTSCHE BOERSE/ADR (DBOEY), T. Rowe Price Group (TROW), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL Fcstone (INTL), OTC Markets Group (OTCM), Yintech Investment (YIN), National (NHLD) and Primus Guaranty (PRSG).

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Paypal (PYPL), Boeing (BA), Netflix (NFLX), Mastercard (MA), Visa (V), Intel (INTC), Bank of America (BAC), Home Depot (HD) and Walt Disney (DIS).

CME Group's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.84%), BlackRock Inc. (6.65%), BlackRock Inc. (6.63%), Edgewood Management LLC (2.11%), Janus Henderson Group PLC (1.54%) and Northern Trust Corp (1.18%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jack J Tobin, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Leo Melamed, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Quest Capital Management Inc. ADV, Mizuho Bank Ltd., Renaissance Technologies LLC, Janus Henderson Group PLC, Point72 Asset Management L.P., AQR Capital Management LLC and Vontobel Asset Management Inc.. Company insiders that have sold CME Group company stock in the last year include Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Martin J Gepsman, Ronald A Pankau, Sean Tully, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Parnassus Investments CA, Magellan Asset Management Ltd, Fiera Capital Corp, Amundi Pioneer Asset Management Inc., AKO Capital LLP, Vanguard Group Inc. and Sarasin & Partners LLP. View Insider Buying and Selling for CME Group.

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CME stock can currently be purchased for approximately $211.15.

CME Group has a market capitalization of $75.61 billion and generates $4.31 billion in revenue each year. The financial services provider earns $1.96 billion in net income (profit) each year or $6.82 on an earnings per share basis. CME Group employs 4,590 workers across the globe.View Additional Information About CME Group.

The official website for CME Group is http://www.cmegroup.com/.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]